PROMIS NEUROSCIENCES INC. Stock-Based Compensation
PROMIS NEUROSCIENCES INC. (PMN) reported Stock-Based Compensation of $598.32 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $408.89K, a 92.86% increase year-over-year.
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $189.43K, a 22.78% decline year-over-year.
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $203.17K, a 67.40% decline year-over-year.
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $197.15K, a 62.88% increase year-over-year.
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2025 was $857.63K, a 3.85% increase from fiscal 2024.
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2024 was $825.81K, a 204.12% increase from fiscal 2023.
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2023 was $271.54K, a 44.31% decline from fiscal 2022.
- PROMIS NEUROSCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2022 was $487.63K, a 5.43% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $408.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $598.32K 10-Q · filed 2026-08-13 | $801.49K derived: sum of 3 quarters · filed 2026-08-13 | $998.64K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $189.43K 10-Q · filed 2026-05-12 | $392.60K derived: sum of 2 quarters · filed 2026-05-12 | $589.74K derived: sum of 3 quarters · filed 2026-05-12 | $801.76K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $203.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $400.32K derived: sum of 2 quarters · filed 2026-03-25 | $612.33K derived: sum of 3 quarters · filed 2026-08-13 | $857.63K 10-K · filed 2026-03-25 |
| 2025-09-30 | $197.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $409.16K derived: sum of 2 quarters · filed 2026-08-13 | $654.46K 10-Q · filed 2025-11-12 | $1.28M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $212.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $457.31K 10-Q · filed 2026-08-13 | $1.08M derived: sum of 3 quarters · filed 2026-08-13 | $1.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $245.29K 10-Q · filed 2026-05-12 | $868.48K derived: sum of 2 quarters · filed 2026-05-12 | $989.52K derived: sum of 3 quarters · filed 2026-05-12 | $1.01M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $623.19K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $744.23K derived: sum of 2 quarters · filed 2026-03-25 | $762.22K derived: sum of 3 quarters · filed 2026-03-25 | $825.81K 10-K · filed 2026-03-25 |
| 2024-09-30 | $121.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $139.03K derived: sum of 2 quarters · filed 2025-11-12 | $202.62K 10-Q · filed 2025-11-12 | $207.46K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $81.58K 10-Q · filed 2025-08-13 | $86.42K derived: sum of 3 quarters · filed 2025-08-13 | $86.42K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $63.58K 10-Q · filed 2025-05-12 | $68.42K derived: sum of 2 quarters · filed 2025-05-12 | $68.42K derived: sum of 3 quarters · filed 2025-05-12 | $202.62K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $4.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.84K derived: sum of 2 quarters · filed 2025-03-31 | $139.03K derived: sum of 3 quarters · filed 2025-03-31 | $271.54K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $134.19K derived: sum of 2 quarters · filed 2024-11-14 | $266.70K 10-Q · filed 2024-11-14 | $405.47K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $134.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $266.70K 10-Q · filed 2024-08-08 | $405.47K derived: sum of 3 quarters · filed 2024-08-08 | $514.05K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $132.51K 10-Q · filed 2024-05-14 | $271.28K derived: sum of 2 quarters · filed 2024-05-14 | $379.86K derived: sum of 3 quarters · filed 2024-05-14 | $495.27K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $138.77K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $247.35K derived: sum of 2 quarters · filed 2024-04-01 | $362.76K derived: sum of 3 quarters · filed 2024-04-01 | $487.63K 10-K · filed 2024-04-01 |
| 2022-09-30 | $108.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $224.00K derived: sum of 2 quarters · filed 2023-11-14 | $348.86K 10-Q · filed 2023-11-14 | $467.01K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $115.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $240.28K 10-Q · filed 2023-08-14 | $358.43K derived: sum of 3 quarters · filed 2023-08-14 | $548.05K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $124.86K 10-Q · filed 2023-05-15 | $243.01K derived: sum of 2 quarters · filed 2023-05-15 | $432.64K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $118.15K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $307.78K derived: sum of 2 quarters · filed 2023-03-08 | $515.63K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $189.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $397.48K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $207.85K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |